{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Stallings CE"],"funding":["NICHD NIH HHS"],"pagination":["112128"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10922409"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["583"],"pubmed_abstract":["Pituitary gland function is regulated by the activity of various transcription factors that control cell fate decisions leading to cellular differentiation and hormone production. FOXO1 is necessary for normal somatotrope differentiation and function. Recent in vivo data implicate FOXO1 in the regulation of genes important for somatotrope differentiation including Gh1, Neurod4, and Pou1f1. In the current study, the somatotrope-like cell line GH3 was treated with a FOXO1 inhibitor, resulting in significant reduction in Neurod4 and Gh1 expression. Consistent with these findings, CRISPR/Cas9-mediated deletion of Foxo1 in GH3 cells significantly reduced expression of Gh1 and Neurod4. Chromatin immunoprecipitation sequencing identifies novel FOXO1 binding sites associated with the Neurod4, Gh1,"],"journal":["Molecular and cellular endocrinology"],"pubmed_title":["FOXO1 regulates expression of Neurod4 in the pituitary gland."],"pmcid":["PMC10922409"],"funding_grant_id":["R15 HD107430","R15 HD078885"],"pubmed_authors":["Ellsworth BS","Athul SW","Ukagwu AE","Das P","Jensik PJ","Stallings CE"],"additional_accession":[]},"is_claimable":false,"name":"FOXO1 regulates expression of Neurod4 in the pituitary gland.","description":"Pituitary gland function is regulated by the activity of various transcription factors that control cell fate decisions leading to cellular differentiation and hormone production. FOXO1 is necessary for normal somatotrope differentiation and function. Recent in vivo data implicate FOXO1 in the regulation of genes important for somatotrope differentiation including Gh1, Neurod4, and Pou1f1. In the current study, the somatotrope-like cell line GH3 was treated with a FOXO1 inhibitor, resulting in significant reduction in Neurod4 and Gh1 expression. Consistent with these findings, CRISPR/Cas9-mediated deletion of Foxo1 in GH3 cells significantly reduced expression of Gh1 and Neurod4. Chromatin immunoprecipitation sequencing identifies novel FOXO1 binding sites associated with the Neurod4, Gh1,","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Apr","modification":"2026-06-01T22:59:27.383Z","creation":"2025-07-13T03:04:39.402Z"},"accession":"S-EPMC10922409","cross_references":{"pubmed":["38142853"],"doi":["10.1016/j.mce.2023.112128"]}}